Your browser doesn't support javascript.
loading
Mutations of the Ki-ras oncogene in endometrial carcinoma.
Ignar-Trowbridge, D; Risinger, J I; Dent, G A; Kohler, M; Berchuck, A; McLachlan, J A; Boyd, J.
Afiliação
  • Ignar-Trowbridge D; Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709.
Am J Obstet Gynecol ; 167(1): 227-32, 1992 Jul.
Article em En | MEDLINE | ID: mdl-1442931
ABSTRACT

OBJECTIVE:

The purpose of this study was to assess the extent of involvement of the ras oncogene in endometrial carcinoma. STUDY

DESIGN:

Genomic deoxyribonucleic acid from 30 samples of endometrial carcinoma was examined for point mutations in codons 12, 13, and 61 from the Ha-ras, Ki-ras, and N-ras genes by means of the polymerase chain reaction, slot-blotting, and deoxyribonucleic acid sequencing procedures.

RESULTS:

An apparent somatic mutation of Ki-ras codon 12 in one of 10 paraffin-embedded tumors was confirmed by deoxyribonucleic acid sequence analysis. Two of 20 frozen endometrial carcinoma specimens were also shown to contain a point mutation in Ki-ras codon 12. No correlation between ras mutation and a number of histologic or clinical parameters was observed.

CONCLUSIONS:

These data suggest a potential role for Ki-ras codon 12 mutations in the development of some (10%) endometrial cancers.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Genes ras / Neoplasias do Endométrio / Mutação Puntual Idioma: En Ano de publicação: 1992 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Genes ras / Neoplasias do Endométrio / Mutação Puntual Idioma: En Ano de publicação: 1992 Tipo de documento: Article